PAXMAN receives first order from Teva in Mexico for 17 scalp cooling systems
PAXMAN announces that the company has received a first order from its license partner Teva Pharmaceutical Industries Ltd for 17 scalp cooling systems to Mexico. The systems are to be installed at five cancer centres, three of which will install systems in Mexico City.The order marks a strong start for PAXMANs launch in Mexico since the market approval in April of 2018. At the same time, it is completely in line with the substantial interest that the company has received from both cancer centres and patients in Mexico. “There are a number of renowned cancer centres in Mexico that want to